The latest cancer drugs news
Browsing: Cancer Drug News
Lung cancer trial of RET inhibitor selpercatinib achieves durable responses in majority of patients with RET gene fusions
For patients with non-small cell lung cancers (NSCLC) marked by RET gene fusions, the targeted…
FDA approves carfilzomib and daratumumab with dexamethasone for multiple myeloma
On August 20, 2020, the Food and Drug Administration approved carfilzomib and daratumumab in combination…
Developing precise medicines for triple negative breast cancer
Taking advantage of a cancer cell’s altered metabolism that drives its runaway growth, Princess Margaret…
Molecule secreted by cancer-associated fibroblasts promotes anticancer drug resistance
A joint project led by Kumamoto University (Japan) has discovered a new mechanism for anticancer…
FDA grants priority review to trilaciclib for the treatment of small cell lung cancer
It was announced that the U.S. Food and Drug Administration (FDA) has accepted the New…
Antibiotic overuse reduces bladder cancer survival rates
The over prescribing of antibiotics is reducing survival rates in patients with urothelial carcinoma and…
Potency-enhancing drugs linked to decreased risks in men with colorectal cancer
A new study from Lund University and Region Skåne in Sweden indicates that potency-enhancing PDE5…
PARP inhibitor rucaparib becomes new treatment option for some men with advanced prostate cancer
Results from an international clinical trial found that men with advanced prostate cancer who have…
Combination therapy improves survival outcomes for patients with acute myeloid leukaemia
A combination regimen of venetoclax and azacitidine was safe and improved overall survival (OS) over…
Unlocking how cellular proteins control cancer spread
A new insight into cell signals that control cancer growth and migration could help in…